Monday, 12 August 2024

🌎 Robinhood Markets Upgraded, Kraft Heinz Initiated, Summit Therapeutics Initiated and more...

Ratings changes for EchoStar, New Fortress Energy, Kraft Heinz, Frontier Group, Marin Software, Summit Therapeutics, CRISPR Therapeutics and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
August 12th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 


Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • Alcoa (NYSE:AA) was upgraded by analysts at UBS Group AG from a "sell" rating to a "buy" rating. They now have a $38.00 price target on the stock, up previously from $32.00. This represents a 21.4% upside from the current price of $31.29.
  • Allstate (NYSE:ALL) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $177.00 price target on the stock, up previously from $142.00. This represents a 3.0% upside from the current price of $171.88.
  • Blend Labs (NYSE:BLND) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $4.75 price target on the stock, up previously from $3.00. This represents a 24.3% upside from the current price of $3.82.
  • Blend Labs (NYSE:BLND) was upgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "buy" rating. They now have a $4.75 price target on the stock, up previously from $3.00. This represents a 24.3% upside from the current price of $3.82.
  • Brown & Brown (NYSE:BRO) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $112.00 price target on the stock, up previously from $94.00. This represents a 12.2% upside from the current price of $99.83.
  • CBIZ (NYSE:CBZ) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $86.00 price target on the stock, up previously from $80.00. This represents a 24.8% upside from the current price of $68.90.
  • Churchill Downs (NASDAQ:CHDN) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $155.00 price target on the stock, up previously from $145.00. This represents a 13.5% upside from the current price of $136.59.
  • Coherent (NYSE:COHR) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $75.00 price target on the stock, up previously from $65.00. This represents a 13.0% upside from the current price of $66.40.
  • Camden Property Trust (NYSE:CPT) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "buy" rating. They now have a $147.00 price target on the stock, up previously from $111.00. This represents a 22.0% upside from the current price of $120.48.
  • Diageo (NYSE:DEO) was upgraded by analysts at Royal Bank of Canada from an "underperform" rating to a "sector perform" rating.The current price is $125.22.
  • Goldman Sachs BDC (NYSE:GSBD) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $12.00 price target on the stock, down previously from $14.00. This represents a 12.7% downside from the current price of $13.74.
  • Robinhood Markets (NASDAQ:HOOD) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $23.00 price target on the stock, up previously from $20.00. This represents a 24.7% upside from the current price of $18.44.
  • Liberty Global (NASDAQ:LBTYA) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "neutral" rating. They now have a $21.30 price target on the stock, up previously from $15.50. This represents a 13.7% upside from the current price of $18.73.
  • Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $1,025.00 price target on the stock, up previously from $725.00. This represents a 15.0% upside from the current price of $891.51.
  • Mid-America Apartment Communities (NYSE:MAA) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "buy" rating. They now have a $189.00 price target on the stock, up previously from $144.00. This represents a 23.2% upside from the current price of $153.36.
  • PAR Technology (NYSE:PAR) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $60.00 price target on the stock, up previously from $45.00. This represents a 17.6% upside from the current price of $51.01.
  • PennantPark Floating Rate Capital (NASDAQ:PFLT) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $12.00 price target on the stock. This represents a 9.4% upside from the current price of $10.97.
  • Progressive (NYSE:PGR) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $253.00 price target on the stock. This represents a 13.1% upside from the current price of $223.70.
  • Power Integrations (NASDAQ:POWI) was upgraded by analysts at Northland Securities from a "market perform" rating to an "outperform" rating. They now have a $80.00 price target on the stock. This represents a 31.7% upside from the current price of $60.75.
  • Prudential Financial (NYSE:PRU) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $113.00 price target on the stock. This represents a 3.4% upside from the current price of $109.29.
  • Take-Two Interactive Software (NASDAQ:TTWO) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $179.00 price target on the stock. This represents a 20.3% upside from the current price of $148.82.
  • Zentalis Pharmaceuticals (NASDAQ:ZNTL) was upgraded by analysts at Wedbush from an "underperform" rating to a "neutral" rating. They now have a $4.00 price target on the stock. This represents a 24.2% upside from the current price of $3.22.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • Algonquin Power & Utilities (NYSE:AQN) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $6.00 price target on the stock, down previously from $8.50. This represents a 16.1% upside from the current price of $5.17.
  • Algonquin Power & Utilities (NYSE:AQN) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $5.17.
  • Brighthouse Financial (NASDAQ:BHF) was downgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "underweight" rating. They now have a $40.00 price target on the stock, down previously from $51.00. This represents a 3.1% downside from the current price of $41.26.
  • Bank of Hawaii (NYSE:BOH) was downgraded by analysts at Piper Sandler from a "neutral" rating to an "underweight" rating. They now have a $61.00 price target on the stock, down previously from $70.00. This represents a 4.5% downside from the current price of $63.86.
  • Hillenbrand (NYSE:HI) was downgraded by analysts at DA Davidson from a "buy" rating to a "neutral" rating. They now have a $33.00 price target on the stock, down previously from $54.00. This represents a 1.4% downside from the current price of $33.47.
  • Janus International Group (NYSE:JBI) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "peer perform" rating.The current price is $10.40.
  • Gladstone Land (NASDAQ:LAND) was downgraded by analysts at Maxim Group from a "buy" rating to a "hold" rating.The current price is $13.42.
  • Pacira BioSciences (NASDAQ:PCRX) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $14.00 price target on the stock, down previously from $37.00. This represents a 10.1% upside from the current price of $12.71.
  • Pacira BioSciences (NASDAQ:PCRX) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $12.71.
  • Pacira BioSciences (NASDAQ:PCRX) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $11.00 price target on the stock, down previously from $42.00. This represents a 13.5% downside from the current price of $12.71.
  • QUALCOMM (NASDAQ:QCOM) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "peer perform" rating.The current price is $162.58.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Arcturus Therapeutics (NASDAQ:ARCT) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $70.00 price target on the stock. This represents a 273.3% upside from the current price of $18.75.
  • Ardent Health Partners (NYSE:ARDT) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $21.00 price target on the stock. This represents a 35.0% upside from the current price of $15.56.
  • Ardent Health Partners (NYSE:ARDT) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $23.00 price target on the stock. This represents a 47.8% upside from the current price of $15.56.
  • Ardent Health Partners (NYSE:ARDT) is now covered by analysts at Mizuho. They set an "outperform" rating and a $20.00 price target on the stock. This represents a 28.5% upside from the current price of $15.56.
  • Ardent Health Partners (NYSE:ARDT) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating and a $18.00 price target on the stock. This represents a 15.7% upside from the current price of $15.56.
  • Ardent Health Partners (NYSE:ARDT) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $27.00 price target on the stock. This represents a 73.5% upside from the current price of $15.56.
  • Ardent Health Partners (NYSE:ARDT) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $23.00 price target on the stock. This represents a 47.8% upside from the current price of $15.56.
  • Ardent Health Partners (NYSE:ARDT) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $21.00 price target on the stock. This represents a 35.0% upside from the current price of $15.56.
  • Ardent Health Partners (NYSE:ARDT) is now covered by analysts at Stephens. They set an "overweight" rating and a $24.00 price target on the stock. This represents a 54.2% upside from the current price of $15.56.
  • Ardent Health Partners (NYSE:ARDT) is now covered by analysts at Loop Capital. They set a "buy" rating and a $18.00 price target on the stock. This represents a 15.7% upside from the current price of $15.56.
  • Ardent Health Partners (NYSE:ARDT) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $22.00 price target on the stock. This represents a 41.4% upside from the current price of $15.56.
  • Conagra Brands (NYSE:CAG) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $36.00 price target on the stock. This represents a 20.0% upside from the current price of $29.99.
  • Famous Dave's of America (NASDAQ:DAVE) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $53.00 price target on the stock. This represents a 73.6% upside from the current price of $30.53.
  • First Merchants (NASDAQ:FRME) is now covered by analysts at Hovde Group. They set a "market perform" rating and a $38.00 price target on the stock. This represents a 8.6% upside from the current price of $34.98.
  • Nexters (NASDAQ:GDEV) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $6.00 price target on the stock. This represents a 137.2% upside from the current price of $2.53.
  • GE Vernova (NYSE:GEV) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $215.00 price target on the stock. This represents a 20.4% upside from the current price of $178.53.
  • General Mills (NYSE:GIS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $76.00 price target on the stock. This represents a 10.6% upside from the current price of $68.74.
  • Hershey (NYSE:HSY) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $185.00 price target on the stock. This represents a 6.8% downside from the current price of $198.51.
  • J.Jill (NYSE:JILL) is now covered by analysts at TD Cowen. They set a "hold" rating and a $37.00 price target on the stock. This represents a 5.2% upside from the current price of $35.18.
  • Kellanova (NYSE:K) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $75.00 price target on the stock. This represents a 0.9% upside from the current price of $74.32.
  • Kraft Heinz (NASDAQ:KHC) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $34.00 price target on the stock. This represents a 0.8% downside from the current price of $34.27.
  • LENZ Therapeutics (NASDAQ:LENZ) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $38.00 price target on the stock. This represents a 51.9% upside from the current price of $25.01.
  • Spectral AI (NASDAQ:MDAI) is now covered by analysts at Northland Securities. They set an "outperform" rating and a $6.00 price target on the stock. This represents a 268.1% upside from the current price of $1.63.
  • Mondelez International (NASDAQ:MDLZ) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $80.00 price target on the stock. This represents a 14.6% upside from the current price of $69.80.
  • Morningstar (NASDAQ:MORN) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $352.00 price target on the stock. This represents a 15.6% upside from the current price of $304.49.
  • Summit Therapeutics (NASDAQ:SMMT) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $16.00 price target on the stock. This represents a 42.3% upside from the current price of $11.24.
  • Tempus AI (NASDAQ:TEM) is now covered by analysts at Piper Sandler. They set a "neutral" rating and a $40.00 price target on the stock. This represents a 3.8% upside from the current price of $38.54.
  • TWFG (NASDAQ:TWFG) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $29.00 price target on the stock. This represents a 18.9% upside from the current price of $24.40.
  • TWFG (NASDAQ:TWFG) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $27.00 price target on the stock. This represents a 10.7% upside from the current price of $24.40.
  • TWFG (NASDAQ:TWFG) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $23.00 price target on the stock. This represents a 5.7% downside from the current price of $24.40.
  • TWFG (NASDAQ:TWFG) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $30.00 price target on the stock. This represents a 23.0% upside from the current price of $24.40.
  • TWFG (NASDAQ:TWFG) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $29.00 price target on the stock. This represents a 18.9% upside from the current price of $24.40.
  • TWFG (NASDAQ:TWFG) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $26.50 price target on the stock. This represents a 8.6% upside from the current price of $24.40.
  • TWFG (NASDAQ:TWFG) is now covered by analysts at Keefe, Bruyette & Woods. They set a "market perform" rating and a $27.00 price target on the stock. This represents a 10.7% upside from the current price of $24.40.
  • USCB Financial (NASDAQ:USCB) is now covered by analysts at Hovde Group. They set a "market perform" rating and a $16.00 price target on the stock. This represents a 12.1% upside from the current price of $14.27.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: This technology could swing the election

No comments:

Post a Comment

Deep State ready to "take care" of Elon?

Elon Musk has just exposed the biggest government cover-up of the last century…                                             ...